Biochemical and Biophysical Research Communications 1998-03-17

Biochemical evidence for oligomerization of rat adrenal acyl-coenzyme A:cholesterol acyltransferase.

T Kawasaki, A Miyazaki, H Hakamata, H Matsuda, S Horiuchi

Index: Biochem. Biophys. Res. Commun. 244(2) , 347-52, (1998)

Full Text: HTML

Abstract

Acyl-coenzyme A:cholesterol acyltransferase (ACAT) in rat adrenal was compared with that in rat liver. Immunoblot analyses of the microsomal fractions from adrenal with an anti-human ACAT antibody detected a 45 kDa protein. Upon pretreatment of these microsomal fractions with chemical cross-linkers such as BS3 and Sulfo-EGS, the 45 kDa band decreased with a concomitant increase in high molecular weight proteins (55, approximately 100, and approximately 230 kDa), suggesting that ACAT constitutes oligomers of 45 kDa monomers associated with a 10 kDa protein. In sharp contrast, the same immunoblot analysis of rat liver microsomal fractions identified a 50 kDa protein which was not cross-linked by these cross-linkers. Moreover, when four ACAT inhibitors were tested for their effects on adrenal and liver enzymes, NTE-122, CI-976, and E5324 were more effective for the liver enzyme, whereas 58-035 was much more effective for adrenal ACAT. These biochemical and pharmacological observations support the notion that the rat liver ACAT protein is distinct from the adrenal counterpart.

Related Compounds

  • PD 128042

Related Articles:

cPLA2α and EHD1 interact and regulate the vesiculation of cholesterol-rich, GPI-anchored, protein-containing endosomes.

2012-05-01

[Mol. Biol. Cell 23(10) , 1874-88, (2012)]

Use of acyltransferase inhibitors to block vesicular traffic between the ER and Golgi complex.

2005-01-01

[Meth. Enzymol. 404 , 115-25, (2005)]

A unique lysophospholipid acyltransferase (LPAT) antagonist, CI-976, affects secretory and endocytic membrane trafficking pathways.

2005-07-15

[J. Cell Sci. 118(Pt 14) , 3061-71, (2005)]

In vitro and in vivo disposition of 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide (CI-976). Identification of a novel five-carbon cleavage metabolite in rats.

1997-01-01

[Drug Metab. Dispos. 25(1) , 123-30, (1997)]

The lysophospholipid acyltransferase antagonist CI-976 inhibits a late step in COPII vesicle budding.

2008-05-01

[Traffic 9(5) , 786-97, (2008)]

More Articles...